XML 51 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
4) Stock-based Compensation: Schedule of stock inventive plan changes (Tables)
6 Months Ended
Jun. 30, 2017
Tables/Schedules  
Schedule of stock inventive plan changes

 

Number of Class A Shares

Weighted Average Exercise Price

 

Number of Class C Shares

Weighted Average Exercise Price

Outstanding at December 31, 2016

        741,973

$      4.33

        556,298

$      4.61

Granted

                    -

 

                    -

 

Exercised

                    -

 

       (103,402)

         1.31

Cancelled

                    -

         (24,227)

         1.31

Outstanding at June 30, 2017

        741,973

$      4.33

         428,669

$      5.59

As of June 30, 2017:

Options exercisable

         671,816

$      4.08

         386,669

$      5.40

As of June 30, 2017:

Available options for future grant

         525,682

         227,750

Weighted average contractual term of options

outstanding at June 30, 2017

6.87 years

2.88 years

Weighted average contractual term of options

exercisable at June 30, 2017

6.61 years

2.71 years

Aggregated intrinsic value of options

outstanding at June 30, 2017 (1)

$1,564,592

$449,896

Aggregated intrinsic value of options

exercisable at June 30, 2017 (1)

$1,564,592

$449,896

                                

(1) The Company used a stock price of $6.37 as of June 30, 2017 to derive intrinsic value.

 

A summary of the status of the Company’s stock incentive plans as of June 30, 2016, and the changes during the six months ended June 30, 2016, are presented below:

 

Number of Class A Shares

Weighted Average Exercise Price

 

Number of Class C Shares

Weighted Average Exercise Price

Outstanding at December 31, 2015

        618,261

$      3.89

        577,436

$      3.54

Granted

                    -

 

                    -

 

Exercised

        (28,460)

        2.15

                    -

 

Cancelled

                    -

 

                    -

Outstanding at June 30, 2016

        589,801

$      3.97

        577,436

$      3.54

As of June 30, 2016:

Options exercisable

         519,711

$      3.65

         524,936

$      3.19

As of June 30, 2016:

Available options for future grant

         397,342

          57,750

Weighted average contractual term of options

outstanding at June 30, 2016

7.25 years

2.25 years

Weighted average contractual term of options

exercisable at June 30, 2016

6.96 years

2.03 years

Aggregated intrinsic value of options

outstanding at June 30, 2016 (1)

$755,390

$1,001,904

Aggregated intrinsic value of options

exercisable at June 30, 2016 (1)

$755,390

$1,001,904

                                

(1) The Company used a stock price of $4.89 as of June 30, 2016 to derive intrinsic value.